Crestchem Limited shareholders unanimously approved a final dividend of ₹1.50 per equity share for FY26 and reappointed key management members at its 34th Annual General Meeting (AGM) on August 6, 2026. The meeting, conducted via video conferencing, saw 85 members cast votes representing 968,844 shares for the financial statements and dividend resolutions, with 100% support. This outcome reinforces shareholder confidence in the company’s governance structure and capital return strategy for the fiscal year ended March 31, 2026.

The voting process was scrutinized by Mehul K. Raval of Mehul Raval & Associates, appointed under Section 108 of the Companies Act, 2013. Remote e-voting via the Central Depository Services Limited (CDSL) platform ran from August 3 to August 5, 2026, while live e-voting occurred during the AGM. The results were submitted to BSE Limited on August 7, 2026, pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Voting Results by Resolution

All ordinary and special resolutions placed before the members passed with significant majorities. The financial statements and dividend declaration received unanimous support from all participating members. Reappointment resolutions for directors and related-party remuneration approvals secured over 98% support.

Key Governance Decisions

Shareholders approved the reappointment of Dipak Narendraprasad Patel as Managing Director for five years from July 1, 2026, to June 30, 2031. Additionally, Nirmit Dipak Patel was reappointed as Executive Director for five years from April 1, 2026, to March 31, 2031. The Board also sought approval for the remuneration of Parul Dipak Patel (Manager Administration) and Tansi Nirmit Patel (Secretarial & Accounts Assistant), both relatives of the directors, for five-year terms starting July 1, 2026, and April 1, 2026, respectively. These appointments were approved under Section 188 of the Companies Act, 2013.

Furthermore, shareholders authorized investments in subsidiary companies within permissible limits under Section 186 of the Companies Act, 2013. Chairman Dipak Narendraprasad Patel noted that no adverse comments were raised in the Auditor’s or Secretarial Audit Reports, indicating robust compliance with corporate governance standards.

Crestchem Limited has been penalized ₹1,06,200 by the Bombay Stock Exchange Limited (BSE) for failing to submit its consolidated cash flow statement within the prescribed timeline. The exchange notified the company of the outstanding fine via email on August 4, 2026, at 10:29 AM, citing a violation of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory action highlights compliance risks associated with complex group structures and tight reporting deadlines.

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations. While the BSE communicated the monetary penalty, Crestchem Limited stated that it had not yet received the formal order or direction detailing the imposition of the fine as of the date of the communication. The company is required to pay the outstanding amount to regularize its standing with the exchange.

The delay in filing stemmed from the incorporation of the company’s subsidiary, Oleo Biosciences Private Limited, on March 31, 2026, which was the final day of the financial year. Because the subsidiary was established on the balance sheet date, it had no financial transactions to report as of that date. Consequently, there was no financial data requiring inclusion in the consolidated cash flow statement for the subsidiary, which contributed to the administrative delay in the consolidated filing process.

Financial Impact Assessment

Despite the regulatory breach, Crestchem Limited clarified that the fine will not have a material financial impact on its operations or balance sheet. The management expressed confidence that the exchange may consider a waiver for the penalty given the specific circumstances surrounding the subsidiary’s incorporation. The company emphasized that the absence of transactional data from the newly formed entity meant the omission did not reflect any underlying financial distress or reporting gap in substantive terms.

Nitin S Shah, Company Secretary, Compliance Officer & CFO of Crestchem Limited, signed the disclosure on August 4, 2026. The company has requested the BSE to take the explanation and the pending payment status on record. Investors should note that while the monetary value is immaterial, consistent adherence to listing obligations remains critical for maintaining regulatory goodwill.